Spyre Therapeutics (SYRE) Return on Sales (2015 - 2024)
Spyre Therapeutics (SYRE) posted Return on Sales of 5.29% for Q1 2024, down 38.45% on a QoQ basis from 3.82% in Q4 2023, and down 436.0% year-over-year from 1.58% in Q2 2023.
Spyre Therapeutics (SYRE) Return on Sales (2015 - 2024) Analysis & Trends
Spyre Therapeutics' Return on Sales history runs 9 years deep, the most recent figure standing at 5.29% for Q1 2024.
- Quarterly Return on Sales fell 436.0% year-over-year to 5.29% in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 5.29% (down 463.0% YoY) and the FY2023 annual result came in at 3.82%, down 346.0% from the prior year.
- Return on Sales was 5.29% for Q1 2024 at Spyre Therapeutics, down from 3.82% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2021 and bottomed at 5.29% in Q1 2024.
- A 4-year average of 1.56% and a median of 0.99% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 35 bps — and 2024, when it plunged 436 bps.
- Spyre Therapeutics' Return on Sales stood at 0.06% in 2021, then plunged by 1897 bps to 1.12% in 2022, then tumbled by 241 bps to 3.82% in 2023, then tumbled by 38 bps to 5.29% in 2024.
- Business Quant data shows SYRE's Return on Sales at 5.29% in Q1 2024, 3.82% in Q4 2023, and 2.79% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -5.29% |
| Dec 31, 2023 | -3.82% |
| Sep 30, 2023 | -2.79% |
| Jun 30, 2023 | -3.16% |
| Mar 31, 2023 | -0.93% |
| Dec 31, 2022 | -1.12% |
| Sep 30, 2022 | -1.05% |
| Jun 30, 2022 | -0.36% |
| Mar 31, 2022 | -0.18% |
| Dec 31, 2021 | -0.06% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2019 | -0.25% |
| Dec 31, 2018 | -0.13% |
| Sep 30, 2018 | -0.07% |
| Jun 30, 2018 | -0.04% |
| Mar 31, 2018 | -0.05% |
| Dec 31, 2017 | -0.06% |
| Sep 30, 2017 | -0.06% |
| Jun 30, 2017 | -0.04% |